UCB Pharmaceuticals SWOT Analysis, Competitors & USP

Published by MBA Skool Team, Last Updated: April 12, 2020

SWOT analysis of UCB Pharmaceuticals analyses the brand by its strengths, weaknesses, opportunities & threats. In UCB Pharmaceuticals SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

SWOT Analysis is a proven management framework which enables a brand like UCB Pharmaceuticals to benchmark its business & performance as compared to the competitors. UCB Pharmaceuticals is one of the leading brands in the pharma and healthcare sector.

The table below lists the UCB Pharmaceuticals SWOT (Strengths, Weaknesses, Opportunities, Threats), top UCB Pharmaceuticals competitors and includes its target market, segmentation, positioning & Unique Selling Proposition (USP).

UCB Pharmaceuticals SWOT Analysis, Competitors, Segmentation, Target Market, Positioning, USP & Brand Analysis Table
UCB Pharmaceuticals Brand Analysis
Parent Company

UCB Pharmaceuticals




Pharma and Healthcare

Tagline/ Slogan

Aspiring to be patient centric biopharma leader


It is global biopharma focused on severe diseases with operations in over 40 countries

UCB Pharmaceuticals STP

Central nervous system diseases & immunology

Target Group

Healthcare professionals offering solutions to patients suffering from severe diseases


A global biopharma focused in severe diseases focused in two areas namely CNS & immunology

SWOT Analysis of UCB Pharmaceuticals
UCB Pharmaceuticals Strengths

Below are the Strengths in the SWOT Analysis of UCB Pharmaceuticals:

1. UCB has nearly 9000 well trained employees

2. Strong global presence in over 40 countries

3. It has strong product pipeline with many molecules in last stages of development especially in case of CNS

4. They have four major blockbuster products such as Cimzia, Vimpat, Neutro, Keppra.

UCB Pharmaceuticals Weaknesses

Here are the weaknesses in the UCB Pharmaceuticals SWOT Analysis:

1. Company operates in limited segments of medication for severe diseases only

2. It has limited presence in developing world as majority of revenue comes from America & Europe operations

UCB Pharmaceuticals Opportunities

Following are the Opportunities in UCB Pharmaceuticals SWOT Analysis:

1. There is good scope for development of new treatment options in epilepsy

2.  they can further utilize full potential of their blockbuster drugs

3. Increasing awareness about severe diseases

UCB Pharmaceuticals Threats

The threats in the SWOT Analysis of UCB Pharmaceuticals are as mentioned:

1. Economic instability of euro zone can hurt revenue of company

2. Strong FDA drug development guidelines

3. Increasing competition of other pharma majors in their business segments

UCB Pharmaceuticals Competition
UCB Pharmaceuticals Competitors

Below are the top 4 competitors of UCB Pharmaceuticals:

1. Abbott laboratories
2. Amgen

3. AstraZeneca

4. Forest laboratories

This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to UCB Pharmaceuticals. This section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2500 brands from over 20 industry sectors.

Continue Reading:

The brand names and other brand information used in the SWOT Analysis section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the brand or add a new one to SWOT Analysis section : Contribute

Share this Page on:
Facebook ShareTweetShare on Linkedin